Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Overview

This document will help manufacturers prepare a submission for a notice of compliance for a COVID-19 drug under the Regulations. It also outlines the process for meeting the post-market regulatory requirements.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-07-29

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data